Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC reversal of dabigatran anticoagulation assessed by skin bleeding assays
NL-OMON40643Phase 2Active, not recruiting
- Sponsor
- Department of Vascular Medicine of the Academic Medical Center
- Start
- May 2015
- Modality
- Small Molecules, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of balfaxar, dabigatran, sponsored by Department of Vascular Medicine of the Academic Medical Center. Started May 2015; status: active, not recruiting.
02
Drugs
balfaxardabigatran
Beyond the preview
Go deeper on NL-OMON40643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40643.